Literature DB >> 15192024

Apolipoprotein D and platelet-derived growth factor-BB synergism mediates vascular smooth muscle cell migration.

Wesley C Y Leung1, Allan Lawrie, Sandra Demaries, Hamid Massaeli, Andrea Burry, Shmuel Yablonsky, Jennifer M Sarjeant, Euridiki Fera, Eric Rassart, J Geoffrey Pickering, Marlene Rabinovitch.   

Abstract

We identified apolipoprotein (apo)D in a search for proteins upregulated in a posttranscriptional manner similar to fibronectin in motile smooth muscle cells (SMCs). To address the function of apoD in SMCs, we cloned a partial apoD cDNA from ovine aortic (Ao) SMCs using RT-PCR. We documented a 2.5-fold increase in apoD protein but no increase in apoD mRNA in Ao SMCs 48 hours after a multiwound migration assay (P<0.01). Confocal microscopy revealed prominent perinuclear and trailing edge expression of apoD in migrating SMCs but not in the confluent monolayer. Stimulation of Ao SMCs with 10 ng/mL platelet-derived growth factor (PDGF)-BB increased apoD protein expression (P<0.05). Moreover, PDGF-BB-stimulated migration of human pulmonary artery SMCs was suppressed by knock-down of apoD using RNAi. Stable overexpression of apoD in Ao SMCs cultured in 10% fetal bovine serum promoted random migration by 62% compared with vector-transfected cells (P<0.01). Overexpression of apoD or addition of exogenous apoD to a rat aortic SMC line (A10) stimulated their migration in response to a subthreshold dose of PDGF-BB (P<0.05). This was unrelated to increased phosphorylation of ERK1/2 or of phospholipase C-gamma1, but correlated with enhanced Rac1 activation. This study shows that apoD can be expressed or taken up by SMCs and can regulate their motility in response to growth factors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15192024     DOI: 10.1161/01.RES.0000135482.74178.14

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  12 in total

Review 1.  Apolipoprotein D.

Authors:  Eric Rassart; Frederik Desmarais; Ouafa Najyb; Karl-F Bergeron; Catherine Mounier
Journal:  Gene       Date:  2020-06-15       Impact factor: 3.688

2.  Endothelial cells downregulate apolipoprotein D expression in mural cells through paracrine secretion and Notch signaling.

Authors:  Mohanasundari Pajaniappan; Nancy K Glober; Simone Kennard; Hua Liu; Ning Zhao; Brenda Lilly
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-06-24       Impact factor: 4.733

Review 3.  Breast cancer and metabolic syndrome linked through the plasminogen activator inhibitor-1 cycle.

Authors:  Lea M Beaulieu; Brandi R Whitley; Theodore F Wiesner; Sophie M Rehault; Diane Palmieri; Abdel G Elkahloun; Frank C Church
Journal:  Bioessays       Date:  2007-10       Impact factor: 4.345

4.  Apolipoprotein D Internalization Is a Basigin-dependent Mechanism.

Authors:  Ouafa Najyb; Louise Brissette; Eric Rassart
Journal:  J Biol Chem       Date:  2015-04-27       Impact factor: 5.157

5.  SM22alpha-targeted deletion of bone morphogenetic protein receptor 1A in mice impairs cardiac and vascular development, and influences organogenesis.

Authors:  Nesrine El-Bizri; Christophe Guignabert; Lingli Wang; Alexander Cheng; Kryn Stankunas; Ching-Pin Chang; Yuji Mishina; Marlene Rabinovitch
Journal:  Development       Date:  2008-07-30       Impact factor: 6.868

6.  Identification of apolipoprotein D as a cardioprotective gene using a mouse model of lethal atherosclerotic coronary artery disease.

Authors:  Kosuke Tsukamoto; D R Mani; Jianru Shi; Songwen Zhang; Darrow E Haagensen; Fumiyuki Otsuka; Jian Guan; Jonathan D Smith; Wei Weng; Ronglih Liao; Frank D Kolodgie; Renu Virmani; Monty Krieger
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-30       Impact factor: 11.205

Review 7.  STAT3 signaling in pulmonary arterial hypertension.

Authors:  Roxane Paulin; Jolyane Meloche; Sébastien Bonnet
Journal:  JAKSTAT       Date:  2012-10-01

8.  BMP promotes motility and represses growth of smooth muscle cells by activation of tandem Wnt pathways.

Authors:  Vinicio A de Jesus Perez; Ziad Ali; Tero-Pekka Alastalo; Fumiaki Ikeno; Hirofumi Sawada; Ying-Ju Lai; Thomas Kleisli; Edda Spiekerkoetter; Xiumei Qu; Laura H Rubinos; Euan Ashley; Manuel Amieva; Shoukat Dedhar; Marlene Rabinovitch
Journal:  J Cell Biol       Date:  2011-01-10       Impact factor: 10.539

9.  Evidence of a role for osteoprotegerin in the pathogenesis of pulmonary arterial hypertension.

Authors:  Allan Lawrie; Elizabeth Waterman; Mark Southwood; David Evans; Jay Suntharalingam; Sheila Francis; David Crossman; Peter Croucher; Nicholas Morrell; Christopher Newman
Journal:  Am J Pathol       Date:  2007-12-21       Impact factor: 4.307

10.  Inhibition of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension.

Authors:  Abdul G Hameed; Nadine D Arnold; Janet Chamberlain; Josephine A Pickworth; Claudia Paiva; Sarah Dawson; Simon Cross; Lu Long; Lan Zhao; Nicholas W Morrell; David C Crossman; Christopher M H Newman; David G Kiely; Sheila E Francis; Allan Lawrie
Journal:  J Exp Med       Date:  2012-10-15       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.